Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation)

Catalog No:
ATL-HPA001912-25
$401.00
Application: WB, ICC, IHC 
Clonality: Polyclonal 
Host: Rabbit 
Reactivity: Human, Rat 
Protein Description: transcription factor AP-4 (activating enhancer binding protein 4)
Gene Name: TFAP4
Alternative Gene Name: AP-4, bHLHc41
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000005718: 100%, ENSRNOG00000005227: 100%
Entrez Gene ID: 7023
Uniprot ID: Q01664
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.

Cognate Antibody/Antigen for Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation)
Antigen PrEST Antigen TFAP4 (ATL-APrEST84739)
Documents & Links for Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation)
Datasheet Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation) at Atlas

Documents & Links for Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation)
Datasheet Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation) Datasheet (External Link)
Vendor Page Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation)

Citations for Anti TFAP4 pAb (ATL-HPA001912 w/enhanced validation) – 5 Found
MYCN promotes neuroblastoma malignancy by establishing a regulatory circuit with transcription factor AP4.
Oncotarget. 2016 Aug 23;7(34):54937-54951. doi: 10.18632/oncotarget.10709.  PubMed
Modulation of transcription factor binding and epigenetic regulation of the MLH1 CpG island and shore by polymorphism rs1800734 in colorectal cancer.
Epigenetics. 2017 Jun 3;12(6):441-448. doi: 10.1080/15592294.2017.1305527. Epub 2017 Mar 17.  PubMed
Inhibitory effect of CC chemokine ligand 23 (CCL23)/ transcription factor activating enhancer binding protein 4 (TFAP4) on cell proliferation, invasion and angiogenesis in hepatocellular carcinoma.
Bioengineered. 2022 Jan;13(1):1626-1636. doi: 10.1080/21655979.2021.2021125.  PubMed
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer.
J Exp Med. 2013 Jul 1;210(7):1331-50. doi: 10.1084/jem.20120812. Epub 2013 Jun 10.  PubMed
Soluble Heparin Binding Epidermal Growth Factor-Like Growth Factor Is a Regulator of GALGT2 Expression and GALGT2-Dependent Muscle and Neuromuscular Phenotypes.
Mol Cell Biol. 2019 Jun 27;39(14):e00140-19. doi: 10.1128/MCB.00140-19. Print 2019 Jul 15.  PubMed